NanoPAL™ and Me :
Release Your Worries
and Be Free

NanoPAL™ and Me : Release Your Worries
and Be Free

An Astute Solution

NanoParma™ has developed testing solution that provides an alternative scenario that may prevent a patient with chest pain/dyspnea a drive to the emergency room, long waits of at least 2-hours, duplicative testing, and wildly inflated bills.

reduction in unnecessary *ER visits
for chest pain¹

reduction in unnecessary ER visits
for dyspnea²

reduction in cost of unnecessary
expenditures³

*ER: emergency room

      1.  Sharp AL, et al. Journal of general internal medicine, 37(4), 745–752. https://doi.org/10.1007/s11606-021-06841-2

 

      2. Hutchinson et al. BMC Pulmonary Medicine. (2017) 17:53, DOI 10.1186/s12890-017-0396-4.

 

      3. https://www.goodrx.com/healthcare-access/patient-advocacy/avoid-er-for-non-emergencies

Designed to Release Patients from Worries

Too often dyspnea and chest pain confront ill patients and their families: Should we drive to the ER tonight and lose a night of sleep or take the risk and wait till morning to call a physician?

  • Our portable home reader NanoPAL™ together with our ultra-sensitive SeraParma™ tests helps telehealth physicians assess multiple biomarker testing results, enabling an astute determination for the crucial next steps for a patient while at home.

Designed to Reduce Unnecessary ER Costs

ER services cost up to 12 times as much as a regular physician’s visit and cost more than 32 billion each year.

  • There is strong evidence of the benefits of primary care for both populations and personal health. With only 15 minutes of turnaround time, our solution will accelerate physicians’ decision-making in outpatient settings and reduce 80-90% of the unnecessary hospital ER visits and related expenditures.

Designed to Release Patients from Worries

Too often dyspnea and chest pain confront ill patients and their families: Should we drive to the ER tonight and lose a night of sleep or take the risk and wait till morning to call a physician?

  • Our portable home reader NanoPAL™ together with our ultra-sensitive SeraParma™ tests helps telehealth physicians assess multiple biomarker testing results, enabling an astute determination for the crucial next steps for a patient while at home.

Designed to Reduce Unnecessary ER Costs

ER services cost up to 12 times as much as a regular physician’s visit and cost more than 32 billion each year.

  • There is strong evidence of the benefits of primary care for both populations and personal health. With only 15 minutes of turnaround time, our solution will accelerate physicians’ decision-making in outpatient settings and reduce 80-90% of the unnecessary hospital ER visits and related expenditures.

Our Vision

Shifting the current healthcare expenditure from cure to prevention

  • In addition to our handy home tests and readers, we also will provide a comprehensive online disease and lifestyle management platform for patients.

  • This service will help patients better understand their prognosis of disease and then prevent their conditions from worsening.

  • Patients’ life quality can be improved by reducing hospitalization frequency and unnecessary concerns about false alarms.

  • Ambulatory care and telehealth providers are equipped to resolve most health issues in non-hospital settings.

  • The healthier the insured is, the more profitable the insurer is; payers will be more willing to reimburse home tests and disease management solutions.

Interdisciplinary Teamwork built on TRUST

  • +886-2-7728-9655

  • service@nanoparma.com

@ 2022 NanoParma Biomedical, LLC.

Contacts

  • +886-2-7728-9655

  • service@nanoparma.com

@ 2022 NanoParma Biomedical, LLC.